4,072 Shares in Solventum Corporation $SOLV Purchased by MBB Public Markets I LLC

Key Points

• MBB Public Markets I LLC acquired a new stake of 4,072 shares in Solventum Corporation, valued at approximately $310,000, as reported in their 13F filing with the SEC.
• Solventum's shares are currently down 2.3%, with a market capitalization of $12.35 billion and reported a quarterly EPS of $1.69, surpassing estimates.
• Wall Street analysts have mixed ratings on Solventum, with four analysts recommending a buy and a consensus price target of $85.75 for the stock.

MBB Public Markets I LLC bought a new position in shares of Solventum Corporation (NYSE:SOLV - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,072 shares of the company's stock, valued at approximately $310,000.

Other hedge funds have also modified their holdings of the company. Rossby Financial LCC purchased a new position in shares of Solventum during the first quarter worth approximately $25,000. Strengthening Families & Communities LLC lifted its holdings in shares of Solventum by 376.8% during the first quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock worth $25,000 after purchasing an additional 260 shares during the period. Raiffeisen Bank International AG acquired a new stake in shares of Solventum during the fourth quarter worth $29,000. Hara Capital LLC acquired a new stake in shares of Solventum during the first quarter worth $38,000. Finally, Smartleaf Asset Management LLC lifted its holdings in shares of Solventum by 193.4% during the first quarter. Smartleaf Asset Management LLC now owns 534 shares of the company's stock worth $40,000 after purchasing an additional 352 shares during the period.

Analyst Ratings Changes

SOLV has been the subject of several recent research reports. Wells Fargo & Company increased their price target on Solventum from $79.00 to $82.00 and gave the stock an "equal weight" rating in a report on Monday. Jefferies Financial Group began coverage on Solventum in a report on Thursday, September 11th. They set a "hold" rating and a $80.00 price target for the company. Wall Street Zen downgraded Solventum from a "strong-buy" rating to a "buy" rating in a report on Tuesday, September 9th. KeyCorp began coverage on Solventum in a report on Friday, June 6th. They issued a "sector weight" rating for the company. Finally, Morgan Stanley raised Solventum from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $80.00 to $103.00 in a report on Tuesday, July 15th. Four equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $85.44.

Solventum Price Performance

Shares of NYSE:SOLV traded up $0.76 during midday trading on Tuesday, hitting $73.97. 172,807 shares of the stock were exchanged, compared to its average volume of 1,078,575. The stock has a market cap of $12.83 billion, a P/E ratio of 34.24, a PEG ratio of 2.99 and a beta of 0.53. The company has a current ratio of 1.22, a quick ratio of 0.86 and a debt-to-equity ratio of 2.14. Solventum Corporation has a twelve month low of $60.70 and a twelve month high of $85.92. The company has a 50 day moving average price of $73.03 and a 200-day moving average price of $72.46.

Solventum (NYSE:SOLV - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $1.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.45 by $0.24. The business had revenue of $2.16 billion during the quarter, compared to the consensus estimate of $2.12 billion. Solventum had a return on equity of 29.93% and a net margin of 4.52%.The business's revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.56 EPS. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. On average, research analysts forecast that Solventum Corporation will post 6.58 earnings per share for the current year.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.